Tianjin Huanhu Hospital
52
25
25
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 52 trials
100.0%
+13.4% vs industry average
8%
4 trials in Phase 3/4
8%
1 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (52)
Registry of an Integrated Longitudinal Multimodal Biospecimen Biobank for Primary CNS Lymphoma in China
Role: collaborator
CEST-PROTECT: Proximal Flow Control With a Balloon Guide Catheter Plus Distal Embolic Protection: a Randomised, Open-label Trial Evaluating Cerebral Protection Techniques
Role: collaborator
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)
Role: collaborator
Effectiveness and Biological Mechanism of Direct Ischemic Post-conditioning for Acute Stroke Patients Due to Large Vessel Occlusion
Role: lead
Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment
Role: lead
Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China
Role: collaborator
Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer
Role: collaborator
China Cognition and Aging Study
Role: collaborator
The Chinese Familial Alzheimer's Network
Role: collaborator
The Ketogenic Diet in the Treatment of Alzheimer's Disease
Role: collaborator
Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
Role: lead
Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation
Role: collaborator
Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/ BCMA(QT-019C) in Patients With r/ r Neurological Autoimmune Diseases
Role: lead
Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke
Role: lead
The Preliminary Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke
Role: lead
Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/B Cell Maturation Antigen (CD19/BCMA) in Patients With r/r Neurological Autoimmune Diseases
Role: lead
Ischemic Postconditioning in Acute Stroke Patients Receiving Endovascular Thrombectomy
Role: lead
Combined Recanalization Therapy for Acute Large Vessel Occlusion Stroke
Role: lead
Exploring the Predicting Biomarkers From Mild Cognitive Impairment to Dementia (EBMID)
Role: collaborator
Intra-arterial Albumin Infusion After Endovascular Therapy for Stroke Patients
Role: lead